Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability
Multiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has been hypothesized that hypoxia plays a role in the pathogenesis of MS. This study was undertaken to investigate the reproducibility of non-inv...
Saved in:
Published in | Annals of neurology Vol. 94; no. 6; pp. 1067 - 1079 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.12.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0364-5134 1531-8249 1531-8249 |
DOI | 10.1002/ana.26769 |
Cover
Loading…
Abstract | Multiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has been hypothesized that hypoxia plays a role in the pathogenesis of MS. This study was undertaken to investigate the reproducibility of non-invasively measured cortical microvascular hemoglobin oxygenation (S
O
) using frequency domain near-infrared spectroscopy (fdNIRS), investigate its temporal pattern of hypoxia in people with MS (pwMS), and its relationship with neurocognitive function and mood.
We investigated the reproducibility of fdNIRS measurements. We measured cortical hypoxia in pwMS, and the relationships between S
O
, neurocognitive function, fatigue, and measures of physical disability. Furthermore, we cataloged the temporal pattern of S
O
measured at 1-week intervals for 4 weeks, and at 8 weeks and ~1 year.
We show that fdNIRS parameters were highly reproducible in 7 healthy control participants measured over 6 days (p > 0.05). There was low variability between and within subjects. In line with our previous findings, we show that 33% of pwMS (n = 88) have cortical microvascular hypoxia. Over 8 weeks and at ~1 year, S
O
values for normoxic and hypoxic groups did not change significantly. There was no significant association between cognitive function and S
O
. This conclusion should be revisited as only a small proportion of the relapsing-remitting MS group (21%) was cognitively impaired.
The fdNIRS parameters have high reproducibility and repeatability, and we have demonstrated that hypoxia in MS is a chronic condition, lasting at least a year. The results show a weak relationship between cognitive functioning and oxygenation, indicating future study is required. ANN NEUROL 2023;94:1067-1079. |
---|---|
AbstractList | Multiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has been hypothesized that hypoxia plays a role in the pathogenesis of MS. This study was undertaken to investigate the reproducibility of non-invasively measured cortical microvascular hemoglobin oxygenation (S
O
) using frequency domain near-infrared spectroscopy (fdNIRS), investigate its temporal pattern of hypoxia in people with MS (pwMS), and its relationship with neurocognitive function and mood.
We investigated the reproducibility of fdNIRS measurements. We measured cortical hypoxia in pwMS, and the relationships between S
O
, neurocognitive function, fatigue, and measures of physical disability. Furthermore, we cataloged the temporal pattern of S
O
measured at 1-week intervals for 4 weeks, and at 8 weeks and ~1 year.
We show that fdNIRS parameters were highly reproducible in 7 healthy control participants measured over 6 days (p > 0.05). There was low variability between and within subjects. In line with our previous findings, we show that 33% of pwMS (n = 88) have cortical microvascular hypoxia. Over 8 weeks and at ~1 year, S
O
values for normoxic and hypoxic groups did not change significantly. There was no significant association between cognitive function and S
O
. This conclusion should be revisited as only a small proportion of the relapsing-remitting MS group (21%) was cognitively impaired.
The fdNIRS parameters have high reproducibility and repeatability, and we have demonstrated that hypoxia in MS is a chronic condition, lasting at least a year. The results show a weak relationship between cognitive functioning and oxygenation, indicating future study is required. ANN NEUROL 2023;94:1067-1079. Multiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has been hypothesized that hypoxia plays a role in the pathogenesis of MS. This study was undertaken to investigate the reproducibility of non-invasively measured cortical microvascular hemoglobin oxygenation (St O2 ) using frequency domain near-infrared spectroscopy (fdNIRS), investigate its temporal pattern of hypoxia in people with MS (pwMS), and its relationship with neurocognitive function and mood.OBJECTIVEMultiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has been hypothesized that hypoxia plays a role in the pathogenesis of MS. This study was undertaken to investigate the reproducibility of non-invasively measured cortical microvascular hemoglobin oxygenation (St O2 ) using frequency domain near-infrared spectroscopy (fdNIRS), investigate its temporal pattern of hypoxia in people with MS (pwMS), and its relationship with neurocognitive function and mood.We investigated the reproducibility of fdNIRS measurements. We measured cortical hypoxia in pwMS, and the relationships between St O2 , neurocognitive function, fatigue, and measures of physical disability. Furthermore, we cataloged the temporal pattern of St O2 measured at 1-week intervals for 4 weeks, and at 8 weeks and ~1 year.METHODSWe investigated the reproducibility of fdNIRS measurements. We measured cortical hypoxia in pwMS, and the relationships between St O2 , neurocognitive function, fatigue, and measures of physical disability. Furthermore, we cataloged the temporal pattern of St O2 measured at 1-week intervals for 4 weeks, and at 8 weeks and ~1 year.We show that fdNIRS parameters were highly reproducible in 7 healthy control participants measured over 6 days (p > 0.05). There was low variability between and within subjects. In line with our previous findings, we show that 33% of pwMS (n = 88) have cortical microvascular hypoxia. Over 8 weeks and at ~1 year, St O2 values for normoxic and hypoxic groups did not change significantly. There was no significant association between cognitive function and St O2 . This conclusion should be revisited as only a small proportion of the relapsing-remitting MS group (21%) was cognitively impaired.RESULTSWe show that fdNIRS parameters were highly reproducible in 7 healthy control participants measured over 6 days (p > 0.05). There was low variability between and within subjects. In line with our previous findings, we show that 33% of pwMS (n = 88) have cortical microvascular hypoxia. Over 8 weeks and at ~1 year, St O2 values for normoxic and hypoxic groups did not change significantly. There was no significant association between cognitive function and St O2 . This conclusion should be revisited as only a small proportion of the relapsing-remitting MS group (21%) was cognitively impaired.The fdNIRS parameters have high reproducibility and repeatability, and we have demonstrated that hypoxia in MS is a chronic condition, lasting at least a year. The results show a weak relationship between cognitive functioning and oxygenation, indicating future study is required. ANN NEUROL 2023;94:1067-1079.INTERPRETATIONThe fdNIRS parameters have high reproducibility and repeatability, and we have demonstrated that hypoxia in MS is a chronic condition, lasting at least a year. The results show a weak relationship between cognitive functioning and oxygenation, indicating future study is required. ANN NEUROL 2023;94:1067-1079. ObjectiveMultiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has been hypothesized that hypoxia plays a role in the pathogenesis of MS. This study was undertaken to investigate the reproducibility of non‐invasively measured cortical microvascular hemoglobin oxygenation (StO2) using frequency domain near‐infrared spectroscopy (fdNIRS), investigate its temporal pattern of hypoxia in people with MS (pwMS), and its relationship with neurocognitive function and mood.MethodsWe investigated the reproducibility of fdNIRS measurements. We measured cortical hypoxia in pwMS, and the relationships between StO2, neurocognitive function, fatigue, and measures of physical disability. Furthermore, we cataloged the temporal pattern of StO2 measured at 1‐week intervals for 4 weeks, and at 8 weeks and ~1 year.ResultsWe show that fdNIRS parameters were highly reproducible in 7 healthy control participants measured over 6 days (p > 0.05). There was low variability between and within subjects. In line with our previous findings, we show that 33% of pwMS (n = 88) have cortical microvascular hypoxia. Over 8 weeks and at ~1 year, StO2 values for normoxic and hypoxic groups did not change significantly. There was no significant association between cognitive function and StO2. This conclusion should be revisited as only a small proportion of the relapsing‐remitting MS group (21%) was cognitively impaired.InterpretationThe fdNIRS parameters have high reproducibility and repeatability, and we have demonstrated that hypoxia in MS is a chronic condition, lasting at least a year. The results show a weak relationship between cognitive functioning and oxygenation, indicating future study is required. ANN NEUROL 2023;94:1067–1079 |
Author | Jarvis, Scott Brown, Lenora Dunn, Jeff F. Adingupu, Damilola D. Soroush, Ateyeh Hansen, Ayden Evans, Taelor |
Author_xml | – sequence: 1 givenname: Damilola D. orcidid: 0000-0002-0312-2359 surname: Adingupu fullname: Adingupu, Damilola D. organization: Department of Radiology, Cumming School of Medicine University of Calgary Calgary Canada – sequence: 2 givenname: Taelor surname: Evans fullname: Evans, Taelor organization: Department of Radiology, Cumming School of Medicine University of Calgary Calgary Canada – sequence: 3 givenname: Ateyeh surname: Soroush fullname: Soroush, Ateyeh organization: Department of Radiology, Cumming School of Medicine University of Calgary Calgary Canada, Hotchkiss Brain Institute, Cumming School of Medicine University of Calgary Calgary Canada – sequence: 4 givenname: Ayden surname: Hansen fullname: Hansen, Ayden organization: Department of Radiology, Cumming School of Medicine University of Calgary Calgary Canada – sequence: 5 givenname: Scott surname: Jarvis fullname: Jarvis, Scott organization: Hotchkiss Brain Institute, Cumming School of Medicine University of Calgary Calgary Canada, Alberta Neurologic Centre Calgary Canada – sequence: 6 givenname: Lenora surname: Brown fullname: Brown, Lenora organization: Hotchkiss Brain Institute, Cumming School of Medicine University of Calgary Calgary Canada, Department of Clinical Neurosciences, Cumming School of Medicine University of Calgary Calgary Canada – sequence: 7 givenname: Jeff F. orcidid: 0000-0001-9728-2654 surname: Dunn fullname: Dunn, Jeff F. organization: Department of Radiology, Cumming School of Medicine University of Calgary Calgary Canada, Hotchkiss Brain Institute, Cumming School of Medicine University of Calgary Calgary Canada, Department of Clinical Neurosciences, Cumming School of Medicine University of Calgary Calgary Canada |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37605937$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0c1O3DAQB3CroioL7aEvgCxxKYeAP-I4PqLlU4K2EvQcTRyHGnntYDtS9xF4a7wL7QH1ZNn6zXg0_z2044M3CH2l5JgSwk7AwzFrZKM-oAUVnFYtq9UOWhDe1JWgvN5Feyk9EkJUQ8kntMtlQ4TicoGe781qChEc_gk5m-hxGPEyxGx1ebtaT-GPBWw9vp1dtpMz-E47E0OyCYMf8HVO-M4-eDuWAq8NDh5_N3MMU1rr38GFh22jDV0667eXWwNpjiZtvjqzCXrrbF5_Rh9HcMl8eTv30a-L8_vlVXXz4_J6eXpTaS5VrrQGNqhBKikaPUIz9sNAe90zpilX0ggFYpCEQQ81cNJSKkch25GLgYHUwPfRt9e-UwxPs0m5W9mkjXPgTZhTx1pRq0Zxogo9fEcfwxx9ma6oVinCBeFFHbypuV-ZoZuiXUFcd3-XXMDRK9Blbyma8R-hpNsE2JUAu22AxZ68s9pmyDb4HMG6_1S8AAlrnyw |
CitedBy_id | crossref_primary_10_3390_jcm13216315 crossref_primary_10_1007_s11940_024_00816_4 crossref_primary_10_4274_jmsr_galenos_2024_2024_12_1 crossref_primary_10_5582_bst_2024_01362 |
Cites_doi | 10.1177/1535370216649060 10.1016/j.msard.2018.09.025 10.1007/978-0-387-79948-3_1127 10.1177/1352458515622696 10.1177/1352458518791683 10.1093/jnen/62.1.25 10.1002/ana.24632 10.1093/sleep/30.12.1747 10.1097/WCO.0b013e328346056f 10.3390/jcm9020335 10.3174/ajnr.A3148 10.1117/1.NPh.3.3.031403 10.1002/ana.24006 10.1016/S1474-4422(08)70259-X 10.1016/j.jneumeth.2006.04.013 10.14814/phy2.12378 10.1093/brain/awz144 10.1177/1352458506070750 10.1080/21641846.2014.909963 10.1111/ene.12932 10.1212/WNL.0b013e3181d6b125 10.1186/1471-2377-13-37 10.1016/j.msard.2019.101508 10.5014/ajot.57.5.570 10.1152/physiol.00018.2018 10.1038/srep16477 10.1186/1471-2377-6-27 10.1152/ajpregu.00208.2014 10.1080/23279095.2013.860602 10.1016/j.jns.2014.03.047 10.1117/1.JBO.17.8.081406 10.1073/pnas.1318345110 10.1016/j.apergo.2007.05.008 10.1088/0034-4885/73/7/076701 10.1177/1352458506070624 10.1016/j.neuroimage.2012.03.049 10.1007/s00401-004-0954-8 10.1093/brain/awaa427 10.1016/S0022-510X(02)00421-5 10.3390/ijms22168370 10.3233/JAD-2011-101821 10.1191/1352458505ms1118oa 10.1017/S1355617708080508 10.1088/0031-9155/44/3/015 |
ContentType | Journal Article |
Copyright | 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. – notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 |
DOI | 10.1002/ana.26769 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1531-8249 |
EndPage | 1079 |
ExternalDocumentID | 37605937 10_1002_ana_26769 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: CIHR grantid: PJT-156257 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1L6 1OB 1OC 1ZS 23M 2QL 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEJM AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAWTL AAXRX AAYCA AAYXX AAZKR ABCQN ABCUV ABEML ABIJN ABIVO ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBMB ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUYR AEYWJ AFAZI AFBPY AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AHMBA AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE AJJEV ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CITATION CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN F00 F01 F04 F5P F8P FEDTE FUBAC FYBCS G-S G.N GNP GODZA GOZPB GRPMH H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KD1 KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LXL LXN LXY LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.- Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ TEORI UB1 V2E V8K V9Y VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR X7M XG1 XJT XPP XSW XV2 YOC YQJ ZGI ZRF ZRR ZXP ZZTAW ~IA ~WT ~X8 AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 |
ID | FETCH-LOGICAL-c379t-cca2d9d79756cfa6fbdd1bcb22c1397e59a5d702aba4a308117f578f35d2a7ca3 |
ISSN | 0364-5134 1531-8249 |
IngestDate | Thu Sep 04 15:49:35 EDT 2025 Fri Jul 25 10:43:40 EDT 2025 Mon Jul 21 06:06:33 EDT 2025 Tue Jul 01 02:24:17 EDT 2025 Thu Apr 24 23:01:30 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c379t-cca2d9d79756cfa6fbdd1bcb22c1397e59a5d702aba4a308117f578f35d2a7ca3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9728-2654 0000-0002-0312-2359 |
PMID | 37605937 |
PQID | 2889903503 |
PQPubID | 946345 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_2854969309 proquest_journals_2889903503 pubmed_primary_37605937 crossref_primary_10_1002_ana_26769 crossref_citationtrail_10_1002_ana_26769 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Minneapolis |
PublicationTitle | Annals of neurology |
PublicationTitleAlternate | Ann Neurol |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_42_1 e_1_2_9_20_1 e_1_2_9_40_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
References_xml | – ident: e_1_2_9_40_1 doi: 10.1177/1535370216649060 – ident: e_1_2_9_35_1 doi: 10.1016/j.msard.2018.09.025 – ident: e_1_2_9_19_1 doi: 10.1007/978-0-387-79948-3_1127 – ident: e_1_2_9_23_1 doi: 10.1177/1352458515622696 – ident: e_1_2_9_7_1 doi: 10.1177/1352458518791683 – ident: e_1_2_9_25_1 doi: 10.1093/jnen/62.1.25 – ident: e_1_2_9_5_1 doi: 10.1002/ana.24632 – ident: e_1_2_9_33_1 doi: 10.1093/sleep/30.12.1747 – ident: e_1_2_9_2_1 doi: 10.1097/WCO.0b013e328346056f – ident: e_1_2_9_34_1 doi: 10.3390/jcm9020335 – ident: e_1_2_9_24_1 doi: 10.3174/ajnr.A3148 – ident: e_1_2_9_31_1 doi: 10.1117/1.NPh.3.3.031403 – ident: e_1_2_9_28_1 doi: 10.1002/ana.24006 – ident: e_1_2_9_44_1 doi: 10.1016/S1474-4422(08)70259-X – ident: e_1_2_9_9_1 doi: 10.1016/j.jneumeth.2006.04.013 – ident: e_1_2_9_30_1 doi: 10.14814/phy2.12378 – ident: e_1_2_9_37_1 doi: 10.1093/brain/awz144 – ident: e_1_2_9_43_1 doi: 10.1177/1352458506070750 – ident: e_1_2_9_29_1 doi: 10.1080/21641846.2014.909963 – ident: e_1_2_9_16_1 doi: 10.1111/ene.12932 – ident: e_1_2_9_45_1 doi: 10.1212/WNL.0b013e3181d6b125 – ident: e_1_2_9_12_1 doi: 10.1186/1471-2377-13-37 – ident: e_1_2_9_14_1 doi: 10.1016/j.msard.2019.101508 – ident: e_1_2_9_15_1 doi: 10.5014/ajot.57.5.570 – ident: e_1_2_9_38_1 doi: 10.1152/physiol.00018.2018 – ident: e_1_2_9_3_1 doi: 10.1038/srep16477 – ident: e_1_2_9_17_1 doi: 10.1186/1471-2377-6-27 – ident: e_1_2_9_39_1 doi: 10.1152/ajpregu.00208.2014 – ident: e_1_2_9_20_1 doi: 10.1080/23279095.2013.860602 – ident: e_1_2_9_13_1 doi: 10.1016/j.jns.2014.03.047 – ident: e_1_2_9_32_1 doi: 10.1117/1.JBO.17.8.081406 – ident: e_1_2_9_4_1 doi: 10.1073/pnas.1318345110 – ident: e_1_2_9_41_1 doi: 10.1016/j.apergo.2007.05.008 – ident: e_1_2_9_8_1 doi: 10.1088/0034-4885/73/7/076701 – ident: e_1_2_9_22_1 doi: 10.1177/1352458506070624 – ident: e_1_2_9_10_1 doi: 10.1016/j.neuroimage.2012.03.049 – ident: e_1_2_9_27_1 doi: 10.1007/s00401-004-0954-8 – ident: e_1_2_9_6_1 doi: 10.1093/brain/awaa427 – ident: e_1_2_9_26_1 doi: 10.1016/S0022-510X(02)00421-5 – ident: e_1_2_9_36_1 doi: 10.3390/ijms22168370 – ident: e_1_2_9_42_1 doi: 10.3233/JAD-2011-101821 – ident: e_1_2_9_18_1 doi: 10.1191/1352458505ms1118oa – ident: e_1_2_9_21_1 doi: 10.1017/S1355617708080508 – ident: e_1_2_9_11_1 doi: 10.1088/0031-9155/44/3/015 |
SSID | ssj0009610 |
Score | 2.463707 |
Snippet | Multiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage. It has... ObjectiveMultiple sclerosis (MS) is a degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and axonal damage.... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 1067 |
SubjectTerms | Autoimmune diseases Central nervous system Chronic illnesses Cognition Cognitive ability Demyelination Fatigue - etiology Hemoglobin Humans Hypoxia Infrared spectroscopy Microvasculature Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Near infrared radiation Oxygenation Parameters Pathogenesis Reproducibility Reproducibility of Results |
Title | Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37605937 https://www.proquest.com/docview/2889903503 https://www.proquest.com/docview/2854969309 |
Volume | 94 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dq9MwFA_zCuKL-O30KlF8EKSzS9eueRz3gyl3V_B2sLeSJum1MNuxdeB89M3_2pOvtsMJV1_K6LK07PxycnLyO78g9Jb7NJOCZh7LgtCDKUB4LIp9jw-FT6gYRrEWnp9dRtP56NMiXPR6PzuspW2dDfiPg3Ul_2NVuAd2VVWy_2DZplO4AZ_BvnAFC8P1ZjY2ulJLJbSvEnuaW1GtTXp6ultV3wumEhqzhjUIHcC0WBhh5o_15v1VcV0qtpCuHAAkaLGO1Z5XVE1PXAHlzOQUNQHk1Orz1ntbw60ks9bK7GbtJ2qi3K62hkz_rVjCurqlHDdBfcLksmpIw1fVutpudPZnUsud_No6zdKmjyY7YSvabP6CBB0uiHO5Qy8mRrh0IA_cs37aHIZs8dh1ukoF7-BsYNRlWckGRDF52ynPbfNffk7P5xcXaXK2SG6h2wSWGur4j9MvrQQZjYyihXsjp07lkw9Nx_sxzV8WKjpgSe6je3algScGNg9QT5YP0Z2Z5VI8Qr8cerBFD65y7NCDLXpwUWKHHtygBwMkMKAHd9GDqxL_iR7d1KEHO_SoR7XoeYzm52fJydSzB3N4PBjT2oNRTwQVYzoOI56zKM-EGGY8I4SrBYUMKQvF2CcsYyMW-KqWOYeZIQ9CQdiYs-AJOiqrUj5DeJTFI0klJTxiEMtTRqmgucyFn4c053EfvXN_bcqtar06PGWZGr1tkoIVUm2FPnrTNF0ZqZZDjY6dfVI7kjcpiWMIyoLQD_rodfM1-Fm1ecZKCShPVaUxVeeGQhdPjV2bpyhiWQhx_vMb_PoFutuOgmN0VK-38iXEtXX2SgPvN49Jq8A |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Temporal+Pattern+of+Cortical+Hypoxia+in+Multiple+Sclerosis+and+Its+Significance+on+Neuropsychological+and+Clinical+Measures+of+Disability&rft.jtitle=Annals+of+neurology&rft.au=Adingupu%2C+Damilola+D&rft.au=Evans%2C+Taelor&rft.au=Soroush%2C+Ateyeh&rft.au=Hansen%2C+Ayden&rft.date=2023-12-01&rft.issn=1531-8249&rft.eissn=1531-8249&rft.volume=94&rft.issue=6&rft.spage=1067&rft_id=info:doi/10.1002%2Fana.26769&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-5134&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-5134&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-5134&client=summon |